Squarepoint
BHVN icon

Squarepoint’s Biohaven BHVN Stock Holding History

Squarepoint’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,600
Closed -$396K – 4597
2024
Q4 		$396K Buy
+10,600
New +$495K ﹤0.01% 3934

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's BHVN Position: Q1 2026 in Review

Squarepoint opened a new position in Biohaven (BHVN) in Q1 2026: 177,678 shares worth $1.5M. The stake represents ﹤0.01% of the portfolio and ranks #2424 among its holdings. This is a return to the name: Squarepoint previously reported a position in BHVN as recently as Q3 2025.

Squarepoint first reported a position in BHVN in Q1 2023 and has held it in 6 quarters since. The position peaked at $3.62M in Q3 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Squarepoint held 177,678 shares of Biohaven worth $1.5M as of Q1 2026.
  • Biohaven was a new Squarepoint position in Q1 2026.
  • Biohaven made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2424 holding.
  • Squarepoint first reported a position in Biohaven in Q1 2023 and has held it in 6 quarters since.
  • Squarepoint's Biohaven position peaked at $3.62M in Q3 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.